Cytarabine is used for treating lymphomatous meningitis via intrathecal administration. It was first introduced by Teva Parenteral Medicines Inc in its drug Cytarabine on Approved Prior to Jan 1, 1982. Another drug containing Cytarabine is Depocyt. 11 different companies have introduced drugs containing Cytarabine.

Cytarabine Patents

Given below is the list of patents protecting Cytarabine, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Depocyt	US5723147	Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride	Mar 03, 2015 (Expired)	Pacira Pharms Inc
Depocyt	US5455044	Method for treating neurological disorders	May 14, 2013 (Expired)	Pacira Pharms Inc

Add above patents to watchlist

Cytarabine's Family Patents

Full family tree

Cytarabine Generic API Manufacturers

Several generic applications have been filed for Cytarabine. The first generic version for Cytarabine was by Hikma Pharmaceuticals Usa Inc and was approved on Aug 2, 1989. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on Feb 28, 2022.

Given below is the list of companies who have filed for Cytarabine generic, along with the locations of their manufacturing plants worldwide.